Our focus
We strive to be an industry leader in minimally invasive devices for diagnosing and treating gastrointestinal and pancreaticobiliary conditions.
Kyra’s story
This patient testimonial is sponsored by Boston Scientific. In a study, patients with class III obesity who underwent ESG in conjunction with prescribed diet and exercise counseling achieved an average of over 20% TBWL.
By combining a relentless dedication to developing an evolving portfolio of less-invasive technologies with a spirit of collaboration with healthcare professionals, we’re committed to improving patient care through continuous innovation, product development excellence and world-class support within the gastrointestinal and pancreaticobiliary spaces.